Humberto Contreras-Trujillo
Affiliations: | 2009-2014 | Stanford University School of Medicine, Palo Alto, CA, United States |
Google:
"Humberto Contreras-Trujillo"Parents
Sign in to add mentor| Irving L. Weissman | research assistant | 2009-2014 | Stanford Medical School | |
| (CIRM Bridges Student) | ||||
| Rong Lu | grad student | 2014- | University of Southern California Keck School of Medicine | |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Cheah MT, Chen JY, Sahoo D, et al. (2015) CD14-expressing cancer cells establish the inflammatory and proliferative tumor microenvironment in bladder cancer. Proceedings of the National Academy of Sciences of the United States of America. 112: 4725-30 |
| Rinkevich Y, Montoro DT, Contreras-Trujillo H, et al. (2014) In vivo clonal analysis reveals lineage-restricted progenitor characteristics in mammalian kidney development, maintenance, and regeneration. Cell Reports. 7: 1270-83 |
| Tseng D, Volkmer JP, Willingham SB, et al. (2013) Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response. Proceedings of the National Academy of Sciences of the United States of America. 110: 11103-8 |
| Edris B, Willingham SB, Weiskopf K, et al. (2013) Anti-KIT monoclonal antibody inhibits imatinib-resistant gastrointestinal stromal tumor growth. Proceedings of the National Academy of Sciences of the United States of America. 110: 3501-6 |
| Edris B, Weiskopf K, Volkmer AK, et al. (2012) Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma. Proceedings of the National Academy of Sciences of the United States of America. 109: 6656-61 |
| Willingham SB, Volkmer JP, Gentles AJ, et al. (2012) The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proceedings of the National Academy of Sciences of the United States of America. 109: 6662-7 |
| Volkmer JP, Sahoo D, Chin RK, et al. (2012) Three differentiation states risk-stratify bladder cancer into distinct subtypes. Proceedings of the National Academy of Sciences of the United States of America. 109: 2078-83 |
| Volkmer JP, Sahoo D, Chin RK, et al. (2012) Three differentiation states risk-stratify bladder cancer into distinct subtypes (Proceedings of the National Academy of Sciences of the United States of America (2012) 109, 6 (2078-2083) DOI: 10.1073/pnas.1120605109) Proceedings of the National Academy of Sciences of the United States of America. 109: 3600 |
| Leman E, Huang W, Contreras-Trujillo H, et al. (2012) 1072 INHIBITION OF BLADDER CANCER CELL GROWTH BY TREATMENT WITH SYNTHETICALLY DERIVED ANTI-CANCER PEPTOIDS Journal of Urology. 187 |